{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,18]],"date-time":"2026-05-18T15:50:49Z","timestamp":1779119449331,"version":"3.51.4"},"reference-count":51,"publisher":"BMJ","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Gut"],"published-print":{"date-parts":[[1996,3]]},"abstract":"<jats:p>The metabolism of tauroursodeoxycholic acid orally administered and its effects on the bile acid pool of patients with asymptomatic\/mildly symptomatic primary biliary cirrhosis is described. Patients were randomly assigned 500, 1000, or 1500 mg\/day of tauroursodeoxycholate for six months. Biliary and serum bile acids were measured before and during treatment by gas chromatography-mass spectrometry and by high performance liquid chromatography. During tauroursodeoxycholate administration, the proportion of total ursodeoxycholate in bile reached mean (SEM) 34.4 (4.5)%, 32.8 (2.8)%, and 41.6 (3.0)% with doses of 500, 1000, and 1500 mg\/day, respectively. Significant decreases in the proportions of chenodeoxycholate and cholate resulted. The glycine\/taurine ratio of the biliary bile acid pool decreased from 1.9 at baseline, to 1.1 with the highest dose. Ursodeoxycholate in bile was conjugated with glycine and taurine, indicating that tauroursodeoxycholate undergoes significant deconjugation and reconjugation during its enterohepatic recycling. The proportion of lithocholate in bile remained unchanged. Fasting serum conjugated ursodeoxycholate concentration positively correlated with the tauroursodeoxycholate dose, and the increased proportion of ursodeoxycholate was accompanied by substantial decreases in the endogenous bile acids. Compared with previously published data for ursodeoxycholic acid therapy, these findings indicate that the shift toward a more hydrophilic bile acid pool is greater and potentially more favourable with tauroursodeoxycholate, and this is because of the reduced intestinal biotransformation of tauroursodeoxycholate.<\/jats:p>","DOI":"10.1136\/gut.38.3.439","type":"journal-article","created":{"date-parts":[[2007,9,18]],"date-time":"2007-09-18T17:41:31Z","timestamp":1190137291000},"page":"439-446","source":"Crossref","is-referenced-by-count":45,"title":["Metabolism of orally administered tauroursodeoxycholic acid in patients with primary biliary cirrhosis."],"prefix":"10.1136","volume":"38","author":[{"given":"K D","family":"Setchell","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C M","family":"Rodrigues","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M","family":"Podda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A","family":"Crosignani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"239","published-online":{"date-parts":[[1996,3,1]]},"reference":[{"key":"ref_1","first-page":"834","article-title":"Is ursodeoxycholic acid an effective treatment for primary biliary cirrhosis?","volume":"i:","author":"Poupon, P.; Chretien, Y.; Poupon, R.E.; Ballet, F.; Calmus, Y.; Darnis, F.","year":"1987","unstructured":"Poupon P, Chretien Y, Poupon RE, Ballet F, Calmus Y, Darnis F. Is ursodeoxycholic acid an effective treatment for primary biliary cirrhosis? Lancet 1987; i: 834-6.","journal-title":"Lancet"},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"1268","DOI":"10.1016\/0016-5085(89)91698-3","article-title":"Ursodeoxycholic acid in primary biliary cirrhosis: results of a controlled double-blind trial","volume":"97","author":"Leuschner, U.; Fischer, H.; Kurtz, W.; Guldutuna, S.; Hubner, K.; Hellstern, A.","year":"1989","unstructured":"Leuschner U, Fischer H, Kurtz W, Guldutuna S, Hubner K, Hellstern A, et al. Ursodeoxycholic acid in primary biliary cirrhosis: results of a controlled double-blind trial. Gastroenterology 1989; 97: 1268-74.","journal-title":"Gastroenterology"},{"key":"ref_3","first-page":"664","article-title":"The effect of ursodeoxycholic acid in primary sclerosing cholangitis","volume":"96","author":"Stiehl, A.; Raedsch, R.; Theilmann, L.; Galle, P.","year":"1989","unstructured":"Stiehl A, Raedsch R, Theilmann L, Galle P. The effect of ursodeoxycholic acid in primary sclerosing cholangitis. Gastroenterology 1989; 96: 664A.","journal-title":"Gastroenterology"},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"1044","DOI":"10.1016\/0016-5085(90)90032-V","article-title":"Ursodeoxycholic acid, taurine or a combination of the two for chronic hepatitis","volume":"98","author":"Podda, M.; Ghezzi, C.; Battezzati, P.M.; Crosignani, A.; Zuin, M.; Roda, A.","year":"1990","unstructured":"Podda M, Ghezzi C, Battezzati PM, Crosignani A, Zuin M, Roda A. Ursodeoxycholic acid, taurine or a combination of the two for chronic hepatitis. Gastroenterology 1990; 98: 1044-50.","journal-title":"Gastroenterology"},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1016\/0168-8278(90)90281-U","article-title":"Ursodeoxycholic acid for primary sclerosing cholangitis","volume":"11","author":"true","year":"1990","unstructured":"Chazouilleres 0, Poupon R, Capron JP, Metman EH, Dhumeaux D, Amouretti M, et al. Ursodeoxycholic acid for primary sclerosing cholangitis. Jf Hepatol 1990; 11: 120-3.","journal-title":"Jf Hepatol"},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1016\/S0022-3476(05)81103-5","article-title":"et aL Effects of ursodeoxycholic acid therapy for liver disease associated with cystic fibrosis","volume":"117","author":"Colombo, C.; Setchell, K.D.R.; Podda, M.; Crosignani, A.; Roda, A.; Curcio, L.","year":"1990","unstructured":"Colombo C, Setchell KDR, Podda M, Crosignani A, Roda A, Curcio L, et aL Effects of ursodeoxycholic acid therapy for liver disease associated with cystic fibrosis. Jf Pediatr 1990; 117: 482-9.","journal-title":"Jf Pediatr"},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"1548","DOI":"10.1056\/NEJM199105303242204","article-title":"the UDCA-PBC study group. A multicenter, controlled trial of ursodiol for the treatment of primary biliary cirrhosis","volume":"324","year":"1991","unstructured":"Poupon RE, Balkau B, Eschwege E, Poupon R and the UDCA-PBC study group. A multicenter, controlled trial of ursodiol for the treatment of primary biliary cirrhosis. N Engl_J Med 1991; 324: 1548-54.","journal-title":"N Engl_J Med"},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1002\/hep.1840100404","article-title":"Effect of ursodeoxycholic acid on bile acid metabolism in primary biliary cirrhosis","volume":"10","author":"Batta, A.K.; Salen, G.; Arora, R.; Shefer, S.; Tint, G.S.; Abroon, J.","year":"1989","unstructured":"Batta AK, Salen G, Arora R, Shefer S, Tint GS, Abroon J, et al. Effect of ursodeoxycholic acid on bile acid metabolism in primary biliary cirrhosis. Hepatology 1989; 10: 414-9.","journal-title":"Hepatology"},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1002\/hep.1840110104","article-title":"Hepatic expression of class I and class II major histocompatibility complex molecules in primary biliary cirrhosis: effect of ursodeoxycholic acid","volume":"11","author":"Calmus, Y.; Gane, P.; Rouger, P.; Poupon, R.","year":"1990","unstructured":"Calmus Y, Gane P, Rouger P, Poupon R. Hepatic expression of class I and class II major histocompatibility complex molecules in primary biliary cirrhosis: effect of ursodeoxycholic acid. Hepatology 1990; 11: 12-5.","journal-title":"Hepatology"},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"1342","DOI":"10.1056\/NEJM199405123301903","article-title":"Ursodiol for the long-term treatment of primary biliary cirrhosis","volume":"330","author":"Poupon, R.E.; Poupon, R.; B, Balkau; the UDCA-PBC Study Group","year":"1994","unstructured":"Poupon RE, Poupon R, Balkau B and the UDCA-PBC Study Group. Ursodiol for the long-term treatment of primary biliary cirrhosis. N EngJ Med 1994; 330: 1342-7.","journal-title":"N EngJ Med"},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/S0022-2275(20)38175-X","article-title":"The hydrophobic\/hydrophilic balance of bile salts. Inverse correlation between reversephase high performance liquid chromatographic mobilities and micellar cholesterol-solubilizing capacities","volume":"23","author":"Armstrong, M.J.; Carey, M.C.","year":"1982","unstructured":"Armstrong MJ, Carey MC. The hydrophobic\/hydrophilic balance of bile salts. Inverse correlation between reversephase high performance liquid chromatographic mobilities and micellar cholesterol-solubilizing capacities. JLipid Res 1982; 23: 70-80.","journal-title":"JLipid Res"},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/0306-9877(86)90137-4","article-title":"Bile acid-induced liver toxicity: relation to the hydrophobic-hydrophilic balance of bile acids","volume":"19","author":"Attili, A.F.; Angelico, M.; Cantafora, A.; Alvaro, D.; Capocaccia, L.","year":"1986","unstructured":"Attili AF, Angelico M, Cantafora A, Alvaro D, Capocaccia L. Bile acid-induced liver toxicity: relation to the hydrophobic-hydrophilic balance of bile acids. Med Hypotheses 1986; 19: 57-68.","journal-title":"Med Hypotheses"},{"key":"ref_13","first-page":"13","article-title":"Bile acid hepatotoxicity and the rationale of UDCA therapy in chronic cholestatic liver disease: some hypotheses","volume-title":"Strategies for the treatment of hepatobiliary diseases","author":"Hofmann, A.F.","year":"1990","unstructured":"Hofmann AF. Bile acid hepatotoxicity and the rationale of UDCA therapy in chronic cholestatic liver disease: some hypotheses. In: Paumgartner G, Stiehl A, Barbara L, Roda E, eds. Strategies for the treatment of hepatobiliary diseases. Dordrecht, The Netherlands: Kluwer Academic, 1990; 13-34."},{"issue":"7","key":"ref_14","first-page":"19","article-title":"Quantitative estimation of hydrophobichydrophilic balance of mixed bile salts solutions","volume":"30","author":"Heuman, D.M.","year":"1989","unstructured":"Heuman DM. Quantitative estimation of hydrophobichydrophilic balance of mixed bile salts solutions. J Lipid Res 1989; 30: 7 19-30.","journal-title":"J Lipid Res"},{"key":"ref_15","first-page":"881","article-title":"Tauroursodeoxycholate (TUDC) reduces ductular proliferation and portal inflammation in bile duct-ligated hamsters","volume":"3","author":"Krol, T.; Kitamura, T.; Miyai, K.; Hardison, W.","year":"1983","unstructured":"Krol T, Kitamura T, Miyai K, Hardison W. Tauroursodeoxycholate (TUDC) reduces ductular proliferation and portal inflammation in bile duct-ligated hamsters. Hepatology 1983; 3: 881","journal-title":"Hepatology"},{"key":"ref_16","first-page":"407","article-title":"Tauroursodeoxycholate prevents biliary protein excretion induced by other bile salts in the rat","volume":"248","author":"Kitani, K.; Ohta, M.; Kanai, S.","year":"1985","unstructured":"Kitani K, Ohta M, Kanai S. Tauroursodeoxycholate prevents biliary protein excretion induced by other bile salts in the rat. AmJ'Physiol 1985; 248: 407-17.","journal-title":"AmJ'Physiol"},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1111\/j.1600-0676.1993.tb00642.x","article-title":"Taurine conjugate of ursodeoxycholate plays a major role in the hepatoprotective effect against cholestasis induced by taurochenodeoxycholate in rats","volume":"13","author":"Tsukahara, K.; Kanai, S.; Ohta, M.; Kitani, K.","year":"1993","unstructured":"Tsukahara K, Kanai S, Ohta M, Kitani K. Taurine conjugate of ursodeoxycholate plays a major role in the hepatoprotective effect against cholestasis induced by taurochenodeoxycholate in rats. Liver 1993; 13: 262-9.","journal-title":"Liver"},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"1333","DOI":"10.1016\/0016-5085(94)90027-2","article-title":"Ursodeoxycholate conjugates protect against disruption of cholesterol-rich membranes by bile salts","volume":"106","author":"Heuman, D.M.; Dajaj, R.","year":"1994","unstructured":"Heuman DM, Dajaj R. Ursodeoxycholate conjugates protect against disruption of cholesterol-rich membranes by bile salts. Gastroenterology 1994; 106: 1333-41.","journal-title":"Gastroenterology"},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"1000","DOI":"10.1002\/hep.1840140609","article-title":"Changes in bile acid composition in patients with primary biliary cirrhosis induced by ursodeoxycholic acid administration","volume":"14","author":"Crosignani, A.; Podda, M.; Battezzati, P.M.; Bertolini, E.; Zuin, M.; Watson, D.","year":"1991","unstructured":"Crosignani A, Podda M, Battezzati PM, Bertolini E, Zuin M, Watson D, et al. Changes in bile acid composition in patients with primary biliary cirrhosis induced by ursodeoxycholic acid administration. Hepatology 1991; 14: 1000-7.","journal-title":"Hepatology"},{"issue":"176","key":"ref_20","first-page":"901","article-title":"Tauroursodeoxycholic acid for the treatment of primary biliary cirrhosis: a dose-response study","volume":"18","author":"Crosignani, A.; Battezzati, P.M.; Camisasca, M.; Bertolini, E.; Govini, G.; Zuin, M.","year":"1993","unstructured":"Crosignani A, Battezzati PM, Camisasca M, Bertolini E, Govini G, Zuin M, et al. Tauroursodeoxycholic acid for the treatment of primary biliary cirrhosis: a dose-response study. Hepatology 1993; 18: 176A. 22 Vonk RJ, Kneepkens CMF, Havina R, Kuipers F, Bijleveld CMA. Enterohepatic circulation in man: a single method for the determination of duodenal bile acids. J Lipid Res 1986; 27: 901-4.","journal-title":"Hepatology; Enterohepatic circulation in man: a single method for the determination of duodenal bile acids"},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/0009-8981(82)90190-5","article-title":"A rapid method for the quantitative extraction of bile acids and their conjugates from serum using commercially available reverse-phrase octadecylsilane bonded silica cartridges","volume":"125","author":"Setchell, K.D.R.; Worthington, J.","year":"1982","unstructured":"Setchell KDR, Worthington J. A rapid method for the quantitative extraction of bile acids and their conjugates from serum using commercially available reverse-phrase octadecylsilane bonded silica cartridges. Clin Chim Acta 1982; 125: 135-44.","journal-title":"Clin Chim Acta"},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1016\/S0022-2275(20)41684-0","article-title":"Analysis of metabolic profiles of bile acids in urine using a lipophilic anion exchanger and computerized gas-liquid chromatography-mass spectrometry","volume":"18","author":"Alme, B.; Bremmelgaard, A.; Sjovall, J.; Thomassen, P.","year":"1977","unstructured":"Alme B, Bremmelgaard A, Sjovall J, Thomassen P. Analysis of metabolic profiles of bile acids in urine using a lipophilic anion exchanger and computerized gas-liquid chromatography-mass spectrometry. J Lipid Res 1977; 18: 339-62.","journal-title":"J Lipid Res"},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"1524","DOI":"10.1016\/S0022-2275(20)38586-2","article-title":"Analysis of 3-sulfated and non sulfated bile acids by onestep hydrolysis and high performance liquid chromatography","volume":"28","author":"Hirano, Y.; Miyazaki, H.; Higashidate, S.; Nakayama, F.","year":"1987","unstructured":"Hirano Y, Miyazaki H, Higashidate S, Nakayama F. Analysis of 3-sulfated and non sulfated bile acids by onestep hydrolysis and high performance liquid chromatography. J Lipid Res 1987; 28: 1524-9.","journal-title":"J Lipid Res"},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1016\/0003-2697(69)90020-7","article-title":"A modified gas-liquid chromatographic procedure for the rapid determination ofbile acids in biological fluids","volume":"29","author":"Nair, P.P.; Garcia, C.C.","year":"1969","unstructured":"Nair PP, Garcia CC. A modified gas-liquid chromatographic procedure for the rapid determination ofbile acids in biological fluids. Anal Biochem 1969; 29: 164-6.","journal-title":"Anal Biochem"},{"key":"ref_25","first-page":"167","article-title":"Mass spectrometry of bile acids","volume-title":"The bile acids. vol 4. Methods and applications","author":"Lawson, A.M.; Setchell, K.D.R.","year":"1988","unstructured":"Lawson AM, Setchell KDR. Mass spectrometry of bile acids. In: Setchell KDR, Kritchevsky D, Nair PP, eds. The bile acids. vol 4. Methods and applications. New York: Plenum Press, 1988: 167-267."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1016\/S0022-2275(20)38684-3","article-title":"High pressure liquid chromatographic analysis of conjugated bile acids in human bile: simultaneous resolution of sulfated and unsulfated lithocholyl amidates and the common conjugated bile acids","volume":"28","author":"Rossi, S.S.; Converse, J.L.; Hofmann, A.F.","year":"1987","unstructured":"Rossi SS, Converse JL, Hofmann AF. High pressure liquid chromatographic analysis of conjugated bile acids in human bile: simultaneous resolution of sulfated and unsulfated lithocholyl amidates and the common conjugated bile acids. J Lipid Res 1987; 28: 589-95.","journal-title":"J Lipid Res"},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"1000","DOI":"10.1016\/0016-5085(85)90200-8","article-title":"Ursodeoxycholic acid treatment of bile reflux gastritis","volume":"89","author":"Stefaniwsky, A.B.; Tint, G.S.; Speck, J.; Shefer, S.; Salen, G.","year":"1985","unstructured":"Stefaniwsky AB, Tint GS, Speck J, Shefer S, Salen G. Ursodeoxycholic acid treatment of bile reflux gastritis. Gastroenterology 1985; 89: 1000-4.","journal-title":"Gastroenterology"},{"key":"ref_28","first-page":"393","article-title":"Ursodeoxycholic acid protects against experimental colon cancer","volume":"106","author":"Holubec, H.; Earnest, D.; Jolley, C.; Bhattacharyya, A.; Allen, C.; Bissonnette, M.","year":"1994","unstructured":"Holubec H, Earnest D, Jolley C, Bhattacharyya A, Allen C, Bissonnette M, et al. Ursodeoxycholic acid protects against experimental colon cancer. Gastroenterology 1994; 106: 393A. 31 Erlinger S. Hypercholeretic bile acids: a clue to mechanism?","journal-title":"Gastroenterology; Erlinger S. Hypercholeretic bile acids: a clue to mechanism"},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1016\/S0168-8278(94)80111-8","article-title":"Effects of ursodeoxycholic acid after 4 to 12 years of therapy in early and later stage of primary biliary cirrhosis","volume":"21","author":"Leuschner, U.; Guildutuna, S.; Imhof, M.; Hubnea, K.; Benjaminov, A.; Leuschner, M.","year":"1994","unstructured":"Leuschner U, Guildutuna S, Imhof M, Hubnea K, Benjaminov A, Leuschner M. Effects of ursodeoxycholic acid after 4 to 12 years of therapy in early and later stage of primary biliary cirrhosis. J Hepatol 1994; 21: 624-33.","journal-title":"J Hepatol"},{"issue":"59-65","key":"ref_30","first-page":"1076","article-title":"Effect of different doses of ursodeoxycholic acid in chronic liver disease","volume":"34","author":"Podda, M.; Ghezzi, C.; Battezzati, P.M.; Bertolini, E.; Crosignani, A.; Petroni, M.L.","year":"1989","unstructured":"Podda M, Ghezzi C, Battezzati PM, Bertolini E, Crosignani A, Petroni ML, et al. Effect of different doses of ursodeoxycholic acid in chronic liver disease. Dig Dis Sci 1989; 34: 59-65S. 34 Crosignani A, Podda M, Bertolini E, Battezzati PM, Zuin M, Setchell KDR. Failure of ursodeoxycholic acid to prevent a cholestatic episode in a patient with benign recurrent intrahepatic cholestasis: a study of bile acid metabolism. Hepatology 1991; 13: 1076-83.","journal-title":"Dig Dis Sci; Failure of ursodeoxycholic acid to prevent a cholestatic episode in a patient with benign recurrent intrahepatic cholestasis: a study of bile acid metabolism"},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/0016-5085(80)90078-5","article-title":"Hypercholeresis induced by ursodeoxycholic acid and 7-ketolithocholic acid in rat: possible role of bicarbonate transport","volume":"79","author":"Dumont, M.; Erlinger, S.; Uchman, S.","year":"1980","unstructured":"Dumont M, Erlinger S, Uchman S. Hypercholeresis induced by ursodeoxycholic acid and 7-ketolithocholic acid in rat: possible role of bicarbonate transport. Gastroenterology 1980; 79: 82-9.","journal-title":"Gastroenterology"},{"key":"ref_32","first-page":"232","article-title":"Ursodeoxycholic acid choleresi:: relationship to biliary HCO and effects of Na -H exchange inhibitors","volume":"254","author":"Renner, E.L.; Lake, JR, Cragoe; EJ, Van Dyke; RW, Scharchmidt; B.F.","year":"1988","unstructured":"Renner EL, Lake JR, Cragoe EJ, Van Dyke RW, Scharchmidt BF. Ursodeoxycholic acid choleresi:: relationship to biliary HCO and effects of Na -H exchange inhibitors. Am J Physiol 1988; 254: G232-41.","journal-title":"Am J Physiol"},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1007\/BF01391378","article-title":"Ursodeoxycholic acid in the treatment of cholesterol cholelithiasis: a review","volume":"27","author":"Bachrach, W.H.; Hofmann, A.F.","year":"1982","unstructured":"Bachrach WH, Hofmann AF. Ursodeoxycholic acid in the treatment of cholesterol cholelithiasis: a review. Dig Dis Sci 1982; 27: 833-56.","journal-title":"Dig Dis Sci"},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"810","DOI":"10.1016\/0016-5085(92)90162-R","article-title":"Intestinal absorption of UDCA in patients with extrahepatic biliary obstruction and bile drainage","volume":"102","author":"Walker, S.; Rudolf, G.; Raedsch, R.; Stiehl, A.","year":"1992","unstructured":"Walker S, Rudolf G, Raedsch R, Stiehl A. Intestinal absorption of UDCA in patients with extrahepatic biliary obstruction and bile drainage. Gastroenterology 1992; 102: 810-5.","journal-title":"Gastroenterology"},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"920","DOI":"10.1002\/hep.1840140527","article-title":"Conjugates of ursodeoxycholate protect against cytotoxicity of more hydrophobic bile salts: in vitro studies in rat hepatocytes and human erythrocytes","volume":"14","author":"Heuman, D.M.; Pandak, W.M.; Hylemon, P.B.; Vlahcevic, Z.R.","year":"1991","unstructured":"Heuman DM, Pandak WM, Hylemon PB, Vlahcevic ZR. Conjugates of ursodeoxycholate protect against cytotoxicity of more hydrophobic bile salts: in vitro studies in rat hepatocytes and human erythrocytes. Hepatology 1991; 14: 920-6.","journal-title":"Hepatology"},{"key":"ref_36","first-page":"301","article-title":"Pharmacology of chenodeoxycholic acid and ursodeoxycholic acid in man","volume-title":"acids and cholesterol in health and disease","author":"Hofmann, A.F.","year":"1983","unstructured":"Hofmann AF. Pharmacology of chenodeoxycholic acid and ursodeoxycholic acid in man. In: Paumgartner G, Stiehl A and Gerok W, eds. Bile acids and cholesterol in health and disease. Dordrecht, The Netherlands: Kluwer Academic, 1983: 301-36."},{"key":"ref_37","first-page":"564","article-title":"Tauroursodeoxycholate increases rat liver ursodeoxycholate and limits lithocholate","volume":"109","author":"Rodrigues, C.M.P.; Kren, B.T.; Steer, C.J.; Setchell, K.D.R.","year":"1995","unstructured":"Rodrigues CMP, Kren BT, Steer CJ, Setchell KDR. Tauroursodeoxycholate increases rat liver ursodeoxycholate and limits lithocholate formation better than ursodeoxycholate. Gastroenterology 1995; 109: 564-72.","journal-title":"formation better than ursodeoxycholate. Gastroenterology"},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1002\/hep.1840120221","article-title":"Comprehensive study of the biliary bile acid composition of patients with cystic fibrosis and associated liver disease before and after UDCA administration","volume":"12","author":"Nakagawa, M.; Colombo, C.; Setchell, K.D.R.","year":"1990","unstructured":"Nakagawa M, Colombo C, Setchell KDR. Comprehensive study of the biliary bile acid composition of patients with cystic fibrosis and associated liver disease before and after UDCA administration. Hepatology 1990; 12: 322-34.","journal-title":"Hepatology"},{"key":"ref_39","first-page":"321","article-title":"Tauroursodeoxycholic acid in the treatment of primary biliary cirrhosis. A controlled study in comparison to ursodeoxycholic acid","volume":"143","author":"Ferri, F.; Bemocchi, P.; Fedeli, S.","year":"1993","unstructured":"Ferri F, Bemocchi P, Fedeli S. Tauroursodeoxycholic acid in the treatment of primary biliary cirrhosis. A controlled study in comparison to ursodeoxycholic acid. Clin Ther 1993; 143: 321-6.","journal-title":"Clin Ther"},{"key":"ref_40","first-page":"335","article-title":"A double blind trial with bile acid therapy in the prophylaxis of cholesterol stone recurrence in the cystic remnant after laparoscopic cholecystectomy. Preliminary report","volume":"106","author":"Cetta, F.; Lombardo, F.; Cappelli, A.; Giubbolini, M.; Bichi, A.; Baldi, C.","year":"1994","unstructured":"Cetta F, Lombardo F, Cappelli A, Giubbolini M, Bichi A, Baldi C. A double blind trial with bile acid therapy in the prophylaxis of cholesterol stone recurrence in the cystic remnant after laparoscopic cholecystectomy. Preliminary report. Gastroenterology 1994; 106: 335A.","journal-title":"Gastroenterology"},{"key":"ref_41","first-page":"1131","volume-title":"Metabolism of ursodeoxycholic acid in man. Gastroenterology 1977; 73","author":"Fedorowski, T.; Salen, G.; Colallilo, A.; Tint, G.S.; Mosbach, E.H.; Hall, J.C.","unstructured":"Fedorowski T, Salen G, Colallilo A, Tint GS, Mosbach EH, Hall JC. Metabolism of ursodeoxycholic acid in man. Gastroenterology 1977; 73: 1131-7."},{"key":"ref_42","first-page":"161","article-title":"Metabolism in man of 7-ketolithocholic acid: precursor of chenoand ursodeoxycholic acids","volume":"239","author":"Fromm, H.; Carlson, G.L.; Hofmann, A.F.; Farivar, S.; Amin, P.","year":"1980","unstructured":"Fromm H, Carlson GL, Hofmann AF, Farivar S, Amin P. Metabolism in man of 7-ketolithocholic acid: precursor of chenoand ursodeoxycholic acids. Am J Physiol 1980; 239: G161-6.","journal-title":"Am J Physiol"},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"1068","DOI":"10.1016\/S0016-5085(79)80079-7","article-title":"Transformation of chenodeoxycholic acid and ursodeoxycholic acid by human intestinal bacteria","volume":"77","author":"Fedorowski, T.; Salen, G.; Tint, G.S.; Mosbach, E.","year":"1979","unstructured":"Fedorowski T, Salen G, Tint GS, Mosbach E. Transformation of chenodeoxycholic acid and ursodeoxycholic acid by human intestinal bacteria. Gastroenterology 1979; 77: 1068-73.","journal-title":"Gastroenterology"},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1002\/hep.1840150409","article-title":"Effect of ursodeoxycholic acid on the kinetics of the major hydrophobic bile acids in health and chronic cholestatic liver disease","volume":"15","author":"Beuers, U.; Spengler, U.; Zwiebel, M.F.; Pauletzki, J.; Fischer, S.; Gustav, P.","year":"1992","unstructured":"Beuers U, Spengler U, Zwiebel MF, Pauletzki J, Fischer S, Gustav P. Effect of ursodeoxycholic acid on the kinetics of the major hydrophobic bile acids in health and chronic cholestatic liver disease. Hepatology 1992; 15: 603-8.","journal-title":"Hepatology"},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"1028","DOI":"10.1002\/hep.1840170614","article-title":"Effect of ursodeoxycholic acid on the kinetics of cholic acid and chenodeoxycholic acid in patients with primary sclerosing cholangitis","volume":"17","author":"Rudolph, G.; Endele, R.; Senn, M.; Stiehl, A.","year":"1993","unstructured":"Rudolph G, Endele R, Senn M, Stiehl A. Effect of ursodeoxycholic acid on the kinetics of cholic acid and chenodeoxycholic acid in patients with primary sclerosing cholangitis. Hepatology 1993; 17: 1028-32.","journal-title":"Hepatology"},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"892","DOI":"10.1002\/hep.1840080431","article-title":"Regulation of bile acid synthesis. II. Effect of bile acid feeding on enzymes regulating hepatic cholesterol and bile acid synthesis in the rat","volume":"8","author":"Heuman, D.M.; Vlahcevic, Z.R.; Bailey, M.L.; Hylemon, P.B.","year":"1988","unstructured":"Heuman DM, Vlahcevic ZR, Bailey ML, Hylemon PB. Regulation of bile acid synthesis. II. Effect of bile acid feeding on enzymes regulating hepatic cholesterol and bile acid synthesis in the rat. Hepatology 1988; 8: 892-7.","journal-title":"Hepatology"},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"1206","DOI":"10.1002\/hep.1840120521","article-title":"Effect of chronic administration of ursodeoxycholic acid on the ileal absorption of endogenous bile acids in man","volume":"12","year":"1990","unstructured":"Marteau P, Chazouilleres 0, Myara A, Jian R, Rambaud JC, Poupon R. Effect of chronic administration of ursodeoxycholic acid on the ileal absorption of endogenous bile acids in man. Hepatology 1990; 12: 1206-8.","journal-title":"Hepatology"},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1016\/0016-5085(90)90834-N","article-title":"Acute effects of ursodeoxycholic and chenodeoxycholic acid on the small intestinal absorption of bile acids","volume":"98","author":"Stiehl, A.; Raedsch, R.; Rudolph, G.","year":"1990","unstructured":"Stiehl A, Raedsch R, Rudolph G. Acute effects of ursodeoxycholic and chenodeoxycholic acid on the small intestinal absorption of bile acids. Gastroenterology 1990; 98: 424-8.","journal-title":"Gastroenterology"},{"key":"ref_49","first-page":"433","article-title":"Systemic spillover of bile acids. EurJ7 Clin Invest","volume":"13","author":"GP, Van Berge-Henegouwen; AF, Hofmann","year":"1983","unstructured":"Van Berge-Henegouwen GP, Hofmann AF. Systemic spillover of bile acids. EurJ7 Clin Invest 1983; 13: 433-7."},{"key":"ref_50","first-page":"379","article-title":"Serum bile acids","volume-title":"The bile acids. vol 4: Methods and Applications","author":"Murphy, G.M.","year":"1988","unstructured":"Murphy GM. Serum bile acids. In: Setchell KDR, Kritchevsky D, Nair PP, eds. The bile acids. vol 4: Methods and Applications. New York: Plenum Press, 1988: 379-403."},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1080\/21548331.1992.11705373","article-title":"Ursodeoxycholic acid therapy: the baby and the bathwater","volume":"27","author":"Javitt, N.B.","year":"1992","unstructured":"Javitt NB. Ursodeoxycholic acid therapy: the baby and the bathwater. Hosp Pract 1992; 27: 12-6.","journal-title":"Hosp Pract"}],"container-title":["Gut"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/gut.38.3.439","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,21]],"date-time":"2025-11-21T17:02:48Z","timestamp":1763744568000},"score":1,"resource":{"primary":{"URL":"https:\/\/gut.bmj.com\/lookup\/doi\/10.1136\/gut.38.3.439"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1996,3]]},"references-count":51,"journal-issue":{"issue":"3","published-online":{"date-parts":[[1996,3,1]]},"published-print":{"date-parts":[[1996,3]]}},"alternative-id":["10.1136\/gut.38.3.439"],"URL":"https:\/\/doi.org\/10.1136\/gut.38.3.439","relation":{},"ISSN":["0017-5749","1468-3288"],"issn-type":[{"value":"0017-5749","type":"print"},{"value":"1468-3288","type":"electronic"}],"subject":[],"published":{"date-parts":[[1996,3]]}}}